OMedLive

CME Presentations

Pediatric Neuroblastoma


Presentations

  • CME
    1.0

    High-Risk Pediatric Neuroblastoma: Best Practices for Effective Care

    Speakers:Jennifer Saggio, MSN, CRNP, CPON, Neuroblastoma Developmental Therapeutics Advanced Practice Nurse
    Navin Pinto, MD, Associate Professor of Pediatrics

    Duration: 60 minutes

    Presented on: June 9, 2016

  • CME
    1.0

    Cases, Challenges, and Controversies on High-Risk Pediatric Neuroblastoma

    Speakers:Jennifer Saggio, MSN, CRNP, CPON, Neuroblastoma Developmental Therapeutics Advanced Practice Nurse
    Jason Shohet, MD, Associate Professor of Pediatric Hematology and Oncology

    Duration: 60 minutes

    Presented on: September 20, 2016


Speakers

  • Jennifer Saggio, MSN, CRNP, CPON

    Jennifer Saggio, MSN, CRNP, CPON

    Jennifer Saggio, MSN, CRNP, CPON

    Neuroblastoma Developmental Therapeutics Advanced Practice Nurse

    Jennifer Saggio received her graduate degree from the University of Pennsylvania’s School of Nursing. She has been a Nurse Practitioner at The Children’s Hospital of Philadelphia for the past 17 years. Over the past 9 years she has been part of the Neuroblastoma Developmental Therapeutics Team specializing in the care of children with relapsed and refractory Neuroblastoma.
  • Navin Pinto, MD

    Navin Pinto, MD

    Navin Pinto, MD

    Associate Professor of Pediatrics

    Navin R. Pinto, MD, is an attending physician at Seattle Children's Hospital and an associate professor of pediatrics at the University of Washington School of Medicine. Dr Pinto’s interests and expertise focus on the use of genetic sequencing technologies to develop more personalized treatment strategies (pharmacogenomics) for children, adolescents, and young adults with solid tumors. He is an active member in numerous professional societies, has authored or co-authored articles published in various peer-reviewed journals, and is involved in several Phase I trials at Seattle Children’s Hospital. He earned his medical degree from the St. Louis University School of Medicine, and completed his pediatrics residency and pediatric hematology-oncology fellowship at the University of Chicago.
  • Jason Shohet, MD

    Jason Shohet, MD

    Jason Shohet, MD

    Associate Professor of Pediatric Hematology and Oncology

    Jason Shohet, MD, PhD, is the research co-director, Neuroblastoma Program, at Texas Children’s Cancer Center and associate professor, Department of Pediatrics, Section of Hematology-Oncology at Baylor College of Medicine, both in Houston. Dr Shohet’s research focuses on developing better molecular targeted therapies for neuroblastoma and other solid tumors, with specific interest in cancer stem cell biology, cellular reprogramming/epigenetics, microRNA function as oncogenes and tumor suppressors, novel tumor markers, molecular targeted therapies for neuroblastoma and solid tumors, and transgenic and orthotopic models for neuroblastoma. He earned his MD and PhD from Boston University School of Medicine, and completed his internship, residency, and fellowship at Baylor College of Medicine.

CME Information

 

Pediatric Patients with High-Risk Neuroblastoma: Perspectives on Diagnosis and Management

 
  

ACKNOWLEDGEMENT This activity is supported by United Therapeutics.

TUITION Complimentary

ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS Live Internet Activity The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Enduring Material The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION Live Activity Thursday, June 9, 2016 from 12:00PM ET – 1:00PM ET. Tuesday, September 20, 2016 from 12:00PM ET – 1:00PM ET.

Enduring Material The enduring material will be available from June 9, 2016 to September 20, 2017.

LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to:

Review treatment options for the management of high-risk pediatric neuroblastoma, including chemotherapy, surgery, radiotherapy, and immunological treatments
Manage immediate and late effects of therapy for pediatric neuroblastoma
Describe patient-related needs associated with agents used for high-risk pediatric neuroblastoma
Evaluate current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma
Provide collaborative comprehensive care for patients with high-risk pediatric neuroblastoma
Counsel patients and caregivers to look for potential treatment outcomes in order to effectively address immediate and late effects of treatment

TARGET AUDIENCE This activity is intended for oncologists, surgeons, nurses, pharmacists, physician assistants, and health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma.

ESTIMATED TIME TO COMPLETE This activity consists of one session, which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION There are no fees to participate in this activity. To participate in the activity, go to www.omedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURE Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship:
Navin Pinto, MD

None

Jennifer Saggio, MSN, CRNP, CPON

Speaker’s Bureau: United Therapeutics

Jason Shohet, MD, PhD

None

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner Reported Financial Relationship:
Hamsa Jaganathan Medical Director PlatformQ Health Education, LLC Has nothing to disclose.
 

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following PlatformQ Health Education, LLC planner, Shaina Druy, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable): This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMERS (if applicable): Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION Accreditation Support: Please contact the Postgraduate Institute for Medicine at www.pimed.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com